Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for ...

Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ...

Masimo Corporation MASI announced preliminary revenues for the fourth quarter and full year 2025 on Monday. Despite the ...

The Irvine-based medical device maker expects Q4 revenue to increase 12% to $411 million and full year revenue to grow 9% to $1.5 billion.

Masimo (Nasdaq: MASI) is a global technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, ...

(Reuters) -Masimo said on Monday a potential joint venture partner is prepared to offer $850 million to $950 million for its consumer business, which includes health and audio products. Masimo and the ...

Masimo (NASDAQ:MASI) supports medical monitoring innovation as nasdaq composite discussions include healthcare technology ...

On January 12, 2026, Masimo announced select preliminary financial results for the fourth quarter and full year 2025, ahead of its full earnings release scheduled for February 26, 2026. For the fourth ...

(Reuters) -Masimo said on Thursday that it is prepared to appoint Politan Capital Management's nominee William Jellison as a director on its board, if the activist investor withdraws its other nominee ...